Dacomitinib in Combination with chemotherapy is effective in lung adenocarcinoma with rare EGFR L747P mutation and bone metastases: a case report - Quiz - MDSpire

Dacomitinib in Combination with chemotherapy is effective in lung adenocarcinoma with rare EGFR L747P mutation and bone metastases: a case report

  • By

  • Weixin Su

  • Haiyan Deng

  • Zhi Yang

  • Anjian Gao

  • Bo Gao

  • May 5, 2026

  • 0 min

Share

Original Source(s)

Dacomitinib in Combination with chemotherapy is effective in lung adenocarcinoma with rare EGFR L747P mutation and bone metastases: a case report

  • by Weixin Su, Haiyan Deng, Zhi Yang, Anjian Gao, Bo Gao

  • May 5, 2026

Related Content

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review